WTA Tour

Sharapova doping ban appeal set for October

2016-09-13 14:09
getty images, tennis, maria sharapova, doping
Maria Sharapova (Getty Images)

Lausanne - A decision on former world No 1 tennis player Maria Sharapova's appeal against a two-year doping ban will be issued in the first week of next month, the Court of Arbitration for Sport said on Tuesday.

Five-times grand slam winner Sharapova, 29, was banned by the International Tennis Federation (ITF) in June following a positive test for the banned drug meldonium during January's Australian Open.

Sharapova was named in Russia's official entry list for the Olympic Games in Rio de Janeiro but the CAS decided in July to defer its decision on her appeal against the ban.

Sharapova is seeking to have her suspension, which was handed down by the ITF in June, wiped out or reduced.

She had called the ITF's ruling "unfairly harsh" as an independent tribunal had found that she had not intentionally violated anti-doping rules.

Meldonium was added to World Anti-doping Agency's list of banned substances at the start of the year after mounting evidence that it boosted blood flow and enhanced athletic performance.

Read more on:    itf  |  cas  |  maria sharapova  |  tennis
NEXT ON SPORT24X

What To Read Next

 

Read News24’s Comments Policy

Live Video Streaming
Video Highlights

Vote

Which is your favourite Grand Slam of the year?

 
 
Men
Women
Love 2 Meet
English Premiership flutter

Take Sport24's "expert" tips at your peril...

Featured

The 2018/19 Absa Premiership season is in full swing. Will Mamelodi Sundowns retain their title? Or can one of Kaizer Chiefs, Orlando Pirates, Wits, SuperSport United - or another team perhaps - snatch glory from the Brazilians? Be sure to visit Sport24 for all the latest news!

Latest blogs
 

Twitter Follow Sport24 on Twitter

Facebook "Like" Sport24's Facebook page

WIN Enter and win with Sport24!

BlackBerry Stay in the loop on your BlackBerry

RSS Feeds Sport news delivered really simply.

 
There are new stories on the homepage. Click here to see them.